I heard a report on TV-Asia’s Community News, in which Dr. Cyrus Poonawalla was interviewed by a reporter about his recent award for “Excellence in Inter-American Public Health”, the first Indian to receive this award in Washington D.C..
According to the following report in the October 6, 2010 issue of BioSpectrum Asia Edition, Bio Technology website (http://www.biospectrumasia.com/content/290910IND14095.asp) report, Dr. Cyrus Poonawalla and his company received an award for contributing toward eliminating Rubella and congenital Rubella syndrome in America.
“Dr. Cyrus Poonawalla receives award from PAHO and PAHEF
Mumbai, Sep 29, 2010: The Pan American Health Organization (PAHO) and the Pan American Health and Education Foundation (PAHEF) have presented Dr Cyrus S Poonawalla, chairman & managing director of Serum Institute of India, with the Award for “Excellence in Inter-American Public Health”, making him the first Indian to get this prestigious honor in Washington DC, USA. Dr. Poonawalla received this award from Dr Mirta Roses Periago, director of the Pan American Health Organization (PAHO) for his extraordinary contribution to eliminate rubella and congenital rubella syndrome in America.
Serum Institute of India is the world’s largest DTP (Triple) and measles vaccine manufacturer. The launch of Serum’s hepatitis-B vaccine in India acted as a catalyst to bring down the prices of the vaccine, and make it affordable for the masses. The company’s products are exported to over 130 countries, worldwide. The company and its Chairman, Dr Cyrus Poonawalla were honored with the Humanitarian Award by Sabin Vaccine Institute, USA, for providing quality vaccines at affordable prices.
Serum Institute of India has demonstrated unparalleled focus in supplying several hundred millions of doses to curb the scourge of rubella (German Measles) and measles to 38 regions in America, for the past 16 years, for routine immunization as well as for mass campaigns.”